Hemocoagulase Atrox

矛头蝮蛇血凝酶

Report date: 2025/07/11 17:57:54

Base Information

Drug NameHemocoagulase Atrox
Drug Alias NameBatroxobin巴曲酶注射用血凝酶巴曲亭Reptilase +[8
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionFibrinogen modulatorsBlood coagulation pathway activation
TargetsFibrinogen
Therapy Area/IndicationsHemorrhageHemorrhagic Disorders
Global Approved IndicationsHemorrhageHemorrhagic Disorders
Approved Indications in ChinaHemorrhageHemorrhagic Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date1989/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSolco Basle AG
China Registration ClassN/A

Develop Information

Active CompaniesSolco Basle AG
Inactive CompaniesN/A
Active IndicationsHemorrhageHemorrhagic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeB01AX
Related LinksKEGG